BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals
Go back to BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals| (NASDAQ: BTAI) | Delayed: 0.18 -0.54 (75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $ | |||
| Open | $0.22 | 52 Week Low | $ | |||
| Day High | $0.23 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $ | |||
| Volume | 57,347,701 | |||||

